What is the role of fluoroquinolones in the treatment of chronic obstructive pulmonary disease (COPD)?

Updated: Nov 13, 2020
  • Author: Paul Kleinschmidt, MD; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print

Use of fluoroquinolones has also been shown to shorten hospital stay, reduce recurrences, and lower costs.

Fortunately, resistance to these agents is still very low, and reserving them for use in populations at risk should preserve their effectiveness for some time. Be aware of the potential for complications with Clostridium difficile colitis, QT prolongation, and musculoskeletal damage from fluoroquinolones, especially in this patient group.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!